The Venture Codex Logo

The Venture Codex

Meneldor

Van Heemstraweg 123-D, Druten, Gelderland, 6651 KH, The Netherlands

Overview

Biopharmaceutical investment company.

Founded

2016

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Germany
Norway
The Netherlands
United Kingdom

Sector focus

Biopharma

Investment portfolio

6rounds
NAMEDATESIZE
TIBEAY Biosciences
Apr 2026Participated
$41 MOther Equity
Tagworks Pharmaceuticals
Jun 2023Participated
$65 MSeries A
Hemispherian
Nov 2022Led
$3 MSeries A
Hemispherian
May 2022Led
$1 MSeed
Atriva Therapeutics
Aug 2020Led
$10 MOther Equity
Aptamer Group
Jun 2018Led
$2 MSeries A
TIBEAY Biosciences
Apr 2026Participated
$41 MOther Equity
Tagworks Pharmaceuticals
Jun 2023Participated
$65 MSeries A
Hemispherian
Nov 2022Led
$3 MSeries A
Hemispherian
May 2022Led
$1 MSeed
Atriva Therapeutics
Aug 2020Led
$10 MOther Equity
Aptamer Group
Jun 2018Led
$2 MSeries A
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Meneldor: 6 funding rounds are recorded in the selected participation categories.All available history.
Meneldor: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A21
Other Equity11

Monthly Deal Activity

Meneldor: 6 deals are recorded across 101 months.All available history.
Meneldor: 6 deals are recorded across 101 months. All available history
MonthDeals
Jun '181
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '201
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Meneldor: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Meneldor: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
Professional Services2

Deal Size Distribution

Meneldor: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Meneldor: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Meneldor: Europe has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Meneldor: Europe has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
Europe6
Meneldor: 11 co-investors are shown, with Oost NL sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Meneldor: 11 co-investors are shown, with Oost NL sharing 2 recorded deals. All available history
Co-investorShared deals
Oost NL2
ATHOS1
Gilde Healthcare1
High-Tech Grunderfonds1
Kistefos1
Kvantia1
Lightstone Ventures1
MIG Capital1
New Enterprise Associates1
Novartis1
Ysios Capital1

Investment Strategy

Meneldor: Led accounts for 67% and participating for 33% of round participation.All available history.
Meneldor: Led accounts for 67% and participating for 33% of round participation. All available history
CategoryDeals (count)Share (%)
Led467%
Participating233%
Meneldor: Single-lead accounts for 75% and co-led for 25% of lead dynamics.All available history.
Meneldor: Single-lead accounts for 75% and co-led for 25% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead375%
Co-led125%

Team

Paul Lelieveld

Founding Partner